Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of restatement of cash flows

v3.21.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of restatement of cash flows - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2021
Jun. 30, 2021
As Reported [Member]    
Condensed Cash Flow Statements, Captions [Line Items]    
Cash Flow from Operating Activities $ (1,595,099) $ (1,839,316)
Cash Flows from Investing Activities (862,500,000) (862,500,000)
Cash Flows from Financing Activities 864,116,292 865,366,291
Supplemental Disclosure of Noncash Financing Activities:    
Offering costs included in accounts payable 250,000  
Offering costs included in accrued expenses 372,369 372,369
Offering costs paid by related party under promissory note 94,099 94,099
Deferred underwriting commissions 30,187,500 30,187,500
Reversal of offering costs included in accounts payable in prior year 113,386 113,386
Derivative warrant liabilities in connection with initial public offering and private placement (39,511,970) (39,511,970)
Initial value of common stock subject to possible redemption 788,774,130 788,774,130
Change in value of common stock subject to possible redemption (3,737,040) (14,422,209)
Adjustment [Member]    
Condensed Cash Flow Statements, Captions [Line Items]    
Cash Flow from Operating Activities
Cash Flows from Investing Activities
Cash Flows from Financing Activities
Supplemental Disclosure of Noncash Financing Activities:    
Offering costs included in accounts payable  
Offering costs included in accrued expenses
Offering costs paid by related party under promissory note
Deferred underwriting commissions
Reversal of offering costs included in accounts payable in prior year
Derivative warrant liabilities in connection with initial public offering and private placement
Initial value of common stock subject to possible redemption (788,774,130) (788,774,130)
Change in value of common stock subject to possible redemption 3,737,040 14,422,209
As Restated [Member]    
Condensed Cash Flow Statements, Captions [Line Items]    
Cash Flow from Operating Activities (1,595,099) (1,839,316)
Cash Flows from Investing Activities (862,500,000) (862,500,000)
Cash Flows from Financing Activities 864,116,292 865,366,291
Supplemental Disclosure of Noncash Financing Activities:    
Offering costs included in accounts payable 250,000  
Offering costs included in accrued expenses 372,369 372,369
Offering costs paid by related party under promissory note 94,099 94,099
Deferred underwriting commissions 30,187,500 30,187,500
Reversal of offering costs included in accounts payable in prior year 113,386 113,386
Derivative warrant liabilities in connection with initial public offering and private placement (39,511,970) (39,511,970)
Initial value of common stock subject to possible redemption
Change in value of common stock subject to possible redemption